Kunming Longjin Pharmaceutical Co Ltd (002750) - Cash Flow Conversion Efficiency

Latest as of September 2023: -0.011x

Based on the latest financial reports, Kunming Longjin Pharmaceutical Co Ltd (002750) has a cash flow conversion efficiency ratio of -0.011x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.69 Million ≈ $-978.60K USD) by net assets (CN¥582.16 Million ≈ $85.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Kunming Longjin Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Kunming Longjin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Kunming Longjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Kunming Longjin Pharmaceutical Co Ltd (002750) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Kunming Longjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kunming Longjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sun Race Sturmey-Archer Inc TW:1526	0.044x
VirTra Inc NASDAQ:VTSI	-0.039x
Generations Bancorp NY Inc NASDAQ:GBNY	0.047x
Century Lithium Corp. V:LCE	-0.005x
Corem Property Group AB (publ) ST:CORE-A	0.001x
Hudson Global Inc NASDAQ:HSON	0.003x
Unite Group PLC LSE:UTG	0.019x
PTL LTD Ordinary Shares NASDAQ:PTLE	-0.445x

Annual Cash Flow Conversion Efficiency for Kunming Longjin Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 002750 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥494.21 Million ≈ $72.32 Million	CN¥-34.24 Million ≈ $-5.01 Million	-0.069x	+4.52%
2023-12-31	CN¥541.13 Million ≈ $79.18 Million	CN¥-39.26 Million ≈ $-5.75 Million	-0.073x	-203.80%
2022-12-31	CN¥604.77 Million ≈ $88.50 Million	CN¥-14.44 Million ≈ $-2.11 Million	-0.024x	-9.42%
2021-12-31	CN¥678.29 Million ≈ $99.26 Million	CN¥-14.80 Million ≈ $-2.17 Million	-0.022x	-126.96%
2020-12-31	CN¥704.71 Million ≈ $103.12 Million	CN¥-6.78 Million ≈ $-991.68K	-0.010x	-258.38%
2019-12-31	CN¥665.89 Million ≈ $97.44 Million	CN¥4.04 Million ≈ $591.66K	0.006x	-87.44%
2018-12-31	CN¥655.93 Million ≈ $95.98 Million	CN¥31.70 Million ≈ $4.64 Million	0.048x	-46.27%
2017-12-31	CN¥645.54 Million ≈ $94.46 Million	CN¥58.06 Million ≈ $8.50 Million	0.090x	-42.15%
2016-12-31	CN¥670.46 Million ≈ $98.11 Million	CN¥104.24 Million ≈ $15.25 Million	0.155x	+32.78%
2015-12-31	CN¥599.41 Million ≈ $87.71 Million	CN¥70.19 Million ≈ $10.27 Million	0.117x	-52.34%
2014-12-31	CN¥285.57 Million ≈ $41.79 Million	CN¥70.16 Million ≈ $10.27 Million	0.246x	-30.30%
2013-12-31	CN¥302.00 Million ≈ $44.19 Million	CN¥106.46 Million ≈ $15.58 Million	0.353x	-12.24%
2012-12-31	CN¥226.94 Million ≈ $33.21 Million	CN¥91.16 Million ≈ $13.34 Million	0.402x	-1.16%
2011-12-31	CN¥186.74 Million ≈ $27.33 Million	CN¥75.90 Million ≈ $11.11 Million	0.406x	--

About Kunming Longjin Pharmaceutical Co Ltd

SHE:002750 China Drug Manufacturers - Specialty & Generic

Market Cap

$34.58 Million

CN¥236.29 Million CNY

Market Cap Rank

#23221 Global

#4714 in China

Share Price

CN¥0.59

Change (1 day)

+0.00%

52-Week Range

CN¥0.59 - CN¥0.59

All Time High

CN¥25.99